A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Cancer vaccines represent a promising personalized therapeutic approach to treating cancer. Here, the authors report the efficacy in a metastatic model of a cancer vaccine-mediated postoperative immunotherapy, based on the coencapsulation of the JQ1 and a photosensitizer ICG together with inactivate...
Guardado en:
Autores principales: | Tingting Wang, Dangge Wang, Haijun Yu, Bing Feng, Fangyuan Zhou, Hanwu Zhang, Lei Zhou, Shi Jiao, Yaping Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f199e800202e4de7bad91d4e281d2a23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Ying-Peng Peng, et al.
Publicado: (2021) -
Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
por: Yan Li, et al.
Publicado: (2021) -
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
por: Jagmohan Singh, et al.
Publicado: (2021) -
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
por: Yifan Xie, et al.
Publicado: (2021) -
Nanotechnology-enhanced immunotherapy for metastatic cancer
por: Peisen Zhang, et al.
Publicado: (2021)